Expression of CD 133 in Invasive Ductal Carcinoma of Breast

BACKGROUND: CD133 is a commonly used cancer stem cell (CSC) marker in breast cancer. However, the association between CD133 expression, with clinicopathological features and prognosis in breast cancer, is poorly understood in the Indian subcontinent. This study was designed to explore the expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Utnal, Preeti Ashok, A, Hemalatha, PN, Sreeramulu, GN, Manjunath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798163/
https://www.ncbi.nlm.nih.gov/pubmed/33112567
http://dx.doi.org/10.31557/APJCP.2020.21.10.3055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798163/
https://www.ncbi.nlm.nih.gov/pubmed/33112567
http://dx.doi.org/10.31557/APJCP.2020.21.10.3055

Ejemplares similares